{
    "nctId": "NCT04328194",
    "briefTitle": "Autotaxin (ATX) as a Marker for Breast Cancer",
    "officialTitle": "Autotaxin (ATX) as a Marker for Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "To estimate the level of serum ATX as a diagnostic marker for breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* The study will be conducted on one hundred female individuals; 80 newly diagnosed breast cancer patients before any treatment or surgical intervention and 20 apparently normal female individuals.\n\nExclusion Criteria:\n\n* Patients with any other type of malignant or benign tumors, renal failure, cardiovascular diseases and liver cirrhosis were excluded from our study.\n* Past history of chemotherapy or surgical treatment of any malignancy.\n* Inflammatory diseases (e.g.bronchitis) or autoimmune diseases (e.g.rheumatoid arthritis).",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}